Which of the following is NOT a recommended method for addressing the harms of opioid use?

The option indicating concurrent use of benzodiazepines with opioids is not a recommended method for addressing the harms of opioid use due to the significant risks associated with this combination. When benzodiazepines are used alongside opioids, there is an increased potential for severe respiratory depression, sedation, and even overdose. This combination can be particularly dangerous because both categories of drugs depress the central nervous system, enhancing the sedative effects and increasing the risk of life-threatening complications.

In contrast, other methods such as conducting urine drug tests to identify undisclosed use play an essential role in ensuring patient safety and ensuring that medications are being used appropriately. Monitoring dosage through Prescription Drug Monitoring Programs (PDMP) can help healthcare providers track patient prescriptions and prevent misuse or over-prescription of opioids. Arranging treatment for opioid use disorder when necessary is a proactive approach to managing addiction and addressing the potential harms that arise from opioid misuse, thereby supporting the patient's overall health and recovery. These strategies are all aligned with best practices in pain management and opioid stewardship.